Skip Navigation

JNCI Journal of the National Cancer Institute 2004 96(17):1263; doi:10.1093/jnci/96.17.1263
© 2004 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Japanese Translation
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Oxford University Press

IN THIS ISSUE

In This Issue

The first 10% of the full text of this article appears below.

Ceramide Pathway of Apoptosis in Neuroblastoma

The lipid second messenger ceramide, which is generated by both acidic and neutral sphingomyelinases or by ceramide synthases, is a common intermediate of many apoptotic pathways. Metabolism of ceramide involves several enzymes, including glucosylceramide synthase and GD3 synthase, and results in the formation of gangliosides (GM3, GD3, and GT3), which in turn promote the generation of reactive oxygen species (ROS) and apoptosis. Lovat et al. (p. 1288) explored how fenretinide, a retinoic acid derivative, induces apoptosis via increases in ceramide levels in neuroblastoma cells. The authors identified a novel pathway of fenretinide-induced ROS generation and . . . [Full Text of this Article]

Blocking Tumor Response to Glucose Deprivation

Probabilities of Death From Breast Cancer and Other Causes

Burden of Illness in Cancer Survivors

Interferon Alfa Immunotherapy and STAT1 Activation

Diet and Exercise Patterns and Cancer and Disease Prevention


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?